This investigation delves into the potential use of halogen bonding to enhance both the short-circuit current (JSC) and overall efficiency of dye-sensitized solar cells (DSSCs). Specifically, we synthesized two distinct dyes, SQI-F and SQI-Cl, and characterized them using FT-IR, 1HNMR, 13C NMR, and mass spectroscopy. These dyes are based on the concept of incorporating halogen atoms within unsymmetrical squaraine structures with a donor–acceptor–donor (D-A-D) configuration. This strategic design aims to achieve optimal performance within DSSCs. We conducted comprehensive assessments using DSSC devices and integrated these synthesized dyes with iodolyte electrolytes, denoted as Z-50 and Z-100. Further enhancements were achieved through the addition of CDCA. Remarkably, in the absence of CDCA, both SQI-F and SQI-Cl dyes displayed distinct photovoltaic characteristics. However, through sensitization with three equivalents of CDCA, a significant improvement in performance became evident. The peak of performance was reached with the SQI-F dye, sensitized with three equivalents of CDCA, and paired with iodolyte Z-100. This combination yielded an impressive DSSC device efficiency of 6.74%, an open-circuit voltage (VOC) of 0.694 V, and a current density (JSC) of 13.67 mA/cm2. This substantial improvement in performance can primarily be attributed to the presence of a σ-hole, which facilitates a robust interaction between the electrolyte and the dyes anchored on the TiO2 substrate. This interaction optimizes the critical dye regeneration process within the DSSCs, ultimately leading to the observed enhancement in efficiency.
In the fields of medicine and pharmaceuticals, a family of compounds known as Schiff bases (SB) plays an important part. Schiff base metal complexes are known to display a broad range of biological activities, each of which is unique in comparison to the others. Anticonvulsants, antibacterial agents, antifungal agents, anticancer agents, antiviral agents, and HIV-fighting medicines are all included in this area of pharmaceuticals. It is general information that the search for new medications and the creation of new medicines is a constant endeavor for scientists and researchers. This is true both in terms of the hunt for new medicines and the manufacturing of new medicines. Antibiotics are losing their effectiveness as microorganisms develop resistance to the drugs that treat them, thus there is a pressing need to discover new substances that might combat this problem. Because of this, the focus of this study was on Schiff bases that had just recently been identified, as well as the metal complexes of those bases that had these qualities.
13 November 2023 in Journal of Molecular Structure